|

NBTXR3 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Locally Advanced Non-Small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Houston, Texas1 trial

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

The University of Texas M. D. Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.